Guidelines for pharmacists performing clinical interventions

1 PSA Committed to better healthGuidelines for pharmacists performing clinical interventions2 Guidelines for pharmacists performing clinical interventions I Pharmaceutical Society of Australia Pharmaceutical Society of Australia Ltd. 2018 This publication contains material that has been provided by the Pharmaceutical Society of Australia (PSA), and may contain material provided by the Commonwealth and third parties. Copyright in material provided by the Commonwealth or third parties belong to them.

2 PSA owns the copyright in the publication as a whole and all material in the publication that has been developed by PSA. In relation to PSA owned material, no part may be reproduced by any process except in accordance with the provisions of the Copyright Act 1968 (Cwth), or the written permission of PSA. Requests and inquiries regarding permission to use PSA material should be addressed to: Pharmaceutical Society of Australia, PO Box 42, Deakin West ACT 2600. If you would like to use material that has been provided by the Commonwealth or third parties, contact them Neither the PSA, nor any person associated with the preparation of this document, accepts liability for any loss which a user of this document may suffer as a result of reliance on the document and, in particular, for.

3 Use of the Guidelines for a purpose for which they were not intended any errors or omissions in the Guidelines any inaccuracy in the information or data on which the Guidelines are based or which is contained in them any interpretations or opinions stated in, or which may be inferred from, the Guidelines . Notification of any inaccuracy or ambiguity found in this document should be made without delay in order that the issue may be investigated and appropriate action taken. Please forward your notification to: Program Delivery Unit, Pharmaceutical Society of Australia, PO Box 42, Deakin West, ACT : 978-0-908185-14-6 Title: Guidelines for pharmacists performing clinical interventionsDate of Publication: December 2018 (updated January 2019)Date of Endorsement by PSA Board: December 2018 Publisher.

4 Pharmaceutical Society of Australia3 Guidelines for pharmacists performing clinical interventions I Pharmaceutical Society of Australia summary 4 Introduction 5 Scope 6 Terminology 7 clinical interventions overview 8 clinical interventions as part of medicines management 9 Relevance to funded programs 10 performing clinical interventions 10 Patient privacy 10 Consent 10 Training

5 10 Policies and procedures 11 Documentation 11 Staff responsibilities 11 Identifying and addressing medication-related problems 11 Communicating and collaborating with other healthcare providers 12 Communicating with patients 13 Follow-up 13 Documentation 13 Methods of documentation 14 Patient history ( clinical )

6 Notes 14 Recording medication-related problems 14 Recording recommendations 20 Monitoring and evaluation 23 Appendix 1 - PROMISe projects 24 Appendix 2 - Guide for documenting clinical notes (SOAP notes) 25 SOAP notes 25 Example 25 Appendix 3 - Referral letter template 26 Appendix 4 - clinical intervention template 27 Appendix 5 - DOCUMENT MRP and recommendation classification codes 28 References 294

7 Guidelines for pharmacists performing clinical interventions I Pharmaceutical Society of Australia summaryAlthough pharmacists routinely undertake clinical interventions as part of their professional duty of care, they may not consistently document these interventions , or document them at all. In addition, some pharmacists may not always recognise that their decisions and actions constitute clinical Guidelines provide information and guidance to assist pharmacists to meet their professional responsibilities, exercise professional judgement and manage risks associated with performing clinical interventions .

8 They provide information and advice to pharmacists on professional issues related to performing clinical interventions . This will help pharmacists to: identify, classify and document medication-related problems (MRPs) and clinical interventions in a professional manner ensure that all important information is recorded effectively and systematically use documented clinical interventions to communicate with other healthcare providers and/or patients, where Guidelines do not replace the need for pharmacists to exercise professional discretion and judgement when performing these tasks in their own practice environment.

9 The Guidelines do not include clinical information or detailed legislative requirements. pharmacists must at all times comply with relevant Commonwealth, state and territory legislation, as well as relevant standards, codes and for pharmacists performing clinical interventions I Pharmaceutical Society of Australia clinical intervention may be defined as any professional activity by the pharmacist directed towards improving the quality use of medicines and resulting in a recommendation for a change in the patient s medication therapy.

10 Means of administration or medication-taking behaviour .1 pharmacists routinely provide clinical interventions to improve the health outcomes of patients. clinical interventions are provided to prevent or address MRPs related to both prescription and non-prescription MRP is defined in the literature as an event or circumstance involving drug treatment that actually or potentially interferes with the patient experiencing an optimum outcome of medical care . Terms used to describe an MRP or subtype include drug-related problem, medication error, adverse drug event, adherence issue and adverse drug 5 MRPs are a major burden on the Australian healthcare system5,6: Of all hospital admissions, an estimated 2 3% are medication related.